Up­dat­ed: SEC chair de­nies a deal to pre­vent Chi­nese com­pa­ny delist­ing is close — re­ports

4 years ago
China
Pharma

Pe­ter Thiel's Mithril leads ef­fort to elect a new slate of in­sid­ers to the board of trou­bled Covid play­er Ada­gio

4 years ago
People
Deals

From pub­lic re­la­tions in­to broad­er mar­ket­ing, GMHC re­brands to re­flect agency net­work evo­lu­tion

4 years ago
Pharma
Marketing

Ver­tex claims suc­cess on its non-opi­oid pain drug, push­ing can­di­date in­to piv­otal tri­als

4 years ago
R&D

Cosela mak­er's ear­ly em­ploy­ees aim to repli­cate 'blue­print' at a new biotech — with an old G1 as­set

4 years ago
Financing
Startups

$35 month­ly in­sulin cap: Re­pub­li­cans de­cry how White House, Dems plan to pay for it

4 years ago
Pharma

Af­ter an RTF and some stern warn­ings, FDA slaps Cy­to­Dyn with two clin­i­cal holds

4 years ago
FDA+

At­ten­tion biotech his­to­ry: Gink­go pours $700M+ on just 2 ex­ecs

4 years ago
Financing

Mer­ck chop­ping 140-plus staffers out of Ac­celeron in wake of $11.5B buy­out

4 years ago
People
Pharma

Ex­clu­sive: Fol­low­ing a se­vere set­back, Bridge­Bio brings out the bud­get axe to chop staff but keeps qui­et on the ...

4 years ago
Pharma

FDA ad­vi­sors vote 6-4 against Amy­lyx's ALS drug, fur­ther dim­ming its hope for reg­u­la­to­ry suc­cess

4 years ago
R&D
FDA+

Safe­ty con­cerns lead FDA to re­ject Ake­bi­a's kid­ney drug

4 years ago
Pharma
FDA+

Pre­ci­sion di­ag­nos­tics biotech wins newest round of in­vestor back­ing in bid to fa­cil­i­tate com­pa­ny ex­pan­sion

4 years ago
Pharma
Diagnostics

As shares tank, Or­chard once again re­struc­tures, shed­ding gene ther­a­py pro­grams and a large part of the staff

4 years ago
People
Pharma

A team at Penn says it has slashed CAR-T cell ther­a­py man­u­fac­tur­ing time­frame to just 24 hours

4 years ago
Pharma
Cell/Gene Tx

Fed­er­al ap­peals court bats back claims No­vo Nordisk’s di­a­betes drug trig­gers pan­cre­at­ic can­cer

4 years ago
Pharma
Law

EMA to clin­i­cal tri­al spon­sors: Use your Covid-re­lat­ed flex­i­bil­i­ties in re­spond­ing to Ukraine cri­sis

4 years ago
Pharma

Fed watch­dog con­firms Trump-era Covid ad cam­paign shenani­gans — and mil­lions mis­spent

4 years ago
Pharma
FDA+

No­var­tis preps launch of Leqvio cam­paign af­ter Acad­e­my Awards ‘splash’

4 years ago
Pharma
Marketing

Pe­ter Hotez and Maria Bot­tazz­i's 'for­got­ten' vac­cine ap­proved in Botswana

4 years ago
Pharma
Coronavirus

Af­ter fail­ing bad­ly on the new com­mer­cial­iza­tion front, Zealand slash­es US staff, sends off CEO and piv­ots back to ...

4 years ago
People
Pharma

SEC to pro­pose new rules to rein in SPACs — re­port; mR­NA start­up lands $27M launch round

4 years ago
News Briefing

On­colyt­ic virus play­er Replimune sees progress on lead pro­gram, but fol­low-up can­di­date's ef­fec­tive­ness re­mains ...

4 years ago
R&D

Lu­ca Santarel­li's Vec­tivBio bags $100M-plus in new fund­ing from li­cens­ing pact, loan

4 years ago
Financing
First page Previous page 548549550551552553554 Next page Last page
A service from the Financial Times